Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.24)
# 412
Out of 5,238 analysts
24
Total ratings
68.18%
Success rate
12.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics | Initiates: Overweight | $7 | $5.39 | +29.87% | 1 | May 5, 2026 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $105 → $100 | $31.77 | +214.76% | 1 | Apr 30, 2026 | |
| APLS Apellis Pharmaceuticals | Downgrades: Neutral | n/a | $41.04 | - | 4 | Apr 1, 2026 | |
| IRD Opus Genetics | Initiates: Overweight | $15 | $5.09 | +194.70% | 1 | Mar 30, 2026 | |
| SRZN Surrozen | Reiterates: Overweight | $40 | $29.00 | +37.93% | 2 | Mar 24, 2026 | |
| KRRO Korro Bio | Maintains: Overweight | $21 → $22 | $12.09 | +81.97% | 3 | Mar 13, 2026 | |
| HROW Harrow | Maintains: Overweight | $94 → $91 | $38.78 | +134.66% | 2 | Mar 4, 2026 | |
| BLTE Belite Bio | Maintains: Overweight | $200 → $266 | $157.36 | +69.04% | 2 | Mar 3, 2026 | |
| WVE Wave Life Sciences | Maintains: Overweight | $34 → $41 | $7.28 | +463.19% | 2 | Feb 5, 2026 | |
| XNCR Xencor | Maintains: Overweight | $40 → $42 | $13.15 | +219.39% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $31 | $23.50 | +31.91% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $7 | $4.35 | +60.92% | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $4.09 | +1,171.39% | 1 | Jul 11, 2025 |
AbCellera Biologics
May 5, 2026
Initiates: Overweight
Price Target: $7
Current: $5.39
Upside: +29.87%
Viking Therapeutics
Apr 30, 2026
Maintains: Overweight
Price Target: $105 → $100
Current: $31.77
Upside: +214.76%
Apellis Pharmaceuticals
Apr 1, 2026
Downgrades: Neutral
Price Target: n/a
Current: $41.04
Upside: -
Opus Genetics
Mar 30, 2026
Initiates: Overweight
Price Target: $15
Current: $5.09
Upside: +194.70%
Surrozen
Mar 24, 2026
Reiterates: Overweight
Price Target: $40
Current: $29.00
Upside: +37.93%
Korro Bio
Mar 13, 2026
Maintains: Overweight
Price Target: $21 → $22
Current: $12.09
Upside: +81.97%
Harrow
Mar 4, 2026
Maintains: Overweight
Price Target: $94 → $91
Current: $38.78
Upside: +134.66%
Belite Bio
Mar 3, 2026
Maintains: Overweight
Price Target: $200 → $266
Current: $157.36
Upside: +69.04%
Wave Life Sciences
Feb 5, 2026
Maintains: Overweight
Price Target: $34 → $41
Current: $7.28
Upside: +463.19%
Xencor
Nov 6, 2025
Maintains: Overweight
Price Target: $40 → $42
Current: $13.15
Upside: +219.39%
Nov 6, 2025
Maintains: Overweight
Price Target: $29 → $31
Current: $23.50
Upside: +31.91%
Oct 2, 2025
Initiates: Overweight
Price Target: $7
Current: $4.35
Upside: +60.92%
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $4.09
Upside: +1,171.39%